Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations.

Arch Pharm Res · 2026 · PMC13136226 · PMID 41963696

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

36%) and a positive trend toward increased OS (15.1 vs. 8.9 months) (Awada et al. 2014 ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.